ABVC BIOPHARMA, INC. cotiza a 0.98 USD y tiene una capitalización bursátil de $26M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Pha…
| Periodo | 2023-05 | 2023-03 | 2022-11 | 2022-08 |
|---|---|---|---|---|
| Real | $-0.60 | $-1.50 | $-1.10 | $-0.60 |
| Estimado | $-0.50 | $-1.50 | $-2.00 | $-1.25 |
| Sorpresa | -20.0% | +0.0% | +45.0% | +52.0% |
| Métrica | ABVC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -2416.0% | -38.6% | -2377.3% |
| Net Margin | -2671.8% | -33.6% | -2638.3% |
| FCF Margin | — | -13.9% | — |
| ROE | -71.2% | -40.4% | -30.8% |
| ROA | -37.5% | -32.0% | -5.5% |
| Current Ratio | 0.41 | 2.84 | -2.43 |
| Debt / Equity | — | 0.28 | — |